A severe case of neuro-Sjögren's syndrome induced by pembrolizumab

Melanoma and Skin Cancer

Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors

Br J Dermatol.

Gault A, Anderson AE, Plummer R, Stewart C, Pratt AG, Rajan N

doi: 10.1111/bjd.19750.Visit the original publication at ncbi.nlm.nih.gov

Melanoma and Skin CancerImmunotherapy

Guillain-Barré Syndrome Triggered by Immune Checkpoint Inhibitors: A Case Report and Literature Review

J Clin Neuromuscul Dis.

Supakornnumporn S, Katirji B

doi: 10.1097/ CND.0000000000000193.

Melanoma and Skin CancerImmunotherapy

Myasthenia triggered by immune checkpoint inhibitors: New case and literature review

Neuromuscul Disord.

Gonzalez NL, Puwanant A, Lu A, Marks SM, Živković SA

doi: 10.1016/j.nmd.2017.01.002.

Immunotherapy

Autoimmune-related bleeding occurring during combined immunotherapy for lung cancer - Case report

Rev Mal Respir.

Eberst G, Lakhzoum W, Tomasini P, Andreotti N, Abcaya J, Mascaux C, Barlesi F

doi: 10.1016/j.rmr.

Immunotherapy

Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature

Mycopathologia.

Oltolini C, Ripa M, Andolina A, Brioschi E, Cilla M, Petrella G, Gregorc V, Castiglioni B, Tassan Din C, Scarpellini P

doi: 10.1007/s11046-018-0291-4.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Acquired generalized lipodystrophy under immune checkpoint inhibition

Br J Dermatol.

Haddad N, Vidal-Trecan T, Baroudjian B, Zagdanski AM, Arangalage D, Battistella M, Gautier JF, Lebbe C, Delyon J, PATIO group

doi: 10.1111/bjd.18124.

Melanoma and Skin Cancer

Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors

Melanoma Res.

Thummalapalli R, Melms JC, Mier J, Izar B

doi: 10.1097/CMR.0000000000000646.

Melanoma and Skin CancerVitiligo

Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy

JAMA Dermatol.

Freites-Martinez A, Kwong BY, Rieger KE, Coit DG, Colevas AD, Lacouture ME

doi: 10.1001/jamadermatol.2017.

Immunotherapy

Autoimmune haemolytic anaemia in a patient with advanced lung adenocarcinoma and chronic lymphocytic leukaemia receiving nivolumab and intravenous immunoglobulin

BMJ Case Rep.

Algaze SD, Park W, Harrington TJ, Mudad R

doi: 10.1136/bcr-2017-221801.

Related content

Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors

Guillain-Barré Syndrome Triggered by Immune Checkpoint Inhibitors: A Case Report and Literature Review

Myasthenia triggered by immune checkpoint inhibitors: New case and literature review

Autoimmune-related bleeding occurring during combined immunotherapy for lung cancer - Case report

Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature

Acquired generalized lipodystrophy under immune checkpoint inhibition

Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors

Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy

Autoimmune haemolytic anaemia in a patient with advanced lung adenocarcinoma and chronic lymphocytic leukaemia receiving nivolumab and intravenous immunoglobulin